Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Similar content being viewed by others Log in or create a free account to read this content Gain free access to this article, as well as selected content from this journal and more on nature.com or References Floyd RA
Ye et al
Tirzepatide improves glycemic control primarily through GIP and GLP-1 receptor activation, which enhances insulin secretion and reduces glucagon levels
it directly reflects the lack of safety data and the potential risks involved
US$ 21.93
US$ 27.66
US$ 23.37
US$ 24.50
)
US$ 26.09
